摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-乙氧基苯甲酸 | 621-51-2

中文名称
3-乙氧基苯甲酸
中文别名
间乙氧基苯甲酸
英文名称
3-ethoxybenzoic acid
英文别名
——
3-乙氧基苯甲酸化学式
CAS
621-51-2
化学式
C9H10O3
mdl
MFCD00016517
分子量
166.177
InChiKey
DTFQMPQJMDEWKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-140 °C (lit.)
  • 沸点:
    254.38°C (rough estimate)
  • 密度:
    1.1708 (rough estimate)
  • 稳定性/保质期:
    远离氧化物。

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 海关编码:
    2918990090
  • 安全说明:
    S26,S36
  • 储存条件:
    请将产品存放在密封容器中,并置于阴凉、干燥的地方。务必远离氧化剂。

SDS

SDS:982caaa07df7252d79c58b123f348404
查看
Material Safety Data Sheet

Section 1. Identification of the substance
3-Ethoxybenzoic acid
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
3-Ethoxybenzoic acid
Ingredient name:
CAS number: 621-51-2

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H10O3
Molecular weight: 166.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质:浅黄色的液态物质。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-乙氧基苯甲酸 在 cytochrome P450 enzyme from Rhodopseudomonas palustrisstrain HaA2氧气还原型辅酶Ⅰ 作用下, 生成 间羟基苯甲酸
    参考文献:
    名称:
    Investigation of the requirements for efficient and selective cytochrome P450 monooxygenase catalysis across different reactions
    摘要:
    The cytochrome P450 metalloenzyme (CYP) CYP199A4 from Rhodopseudomonas palustris HaA2 catalyzes the highly efficient oxidation of para-substituted benzoic acids. Here we determined crystal structures of CYP199A4, and the binding and turnover parameters, with different meta-substituted benzoic acids in order to establish which criteria are important for efficient catalysis. When compared to the para isomers, the meta-substituted benzoic acids were less efficiently oxidized. For example, 3-formylbenzoic acid was oxidized with lower activity than the equivalent para isomer and 3-methoxybenzoic acid did not undergo O-demethylation by CYP199A4. The structural data highlighted that the meta-substituted benzoic acids bound in the enzyme active site in a modified position with incomplete loss of the distal water ligand of the heme moiety. However, for both sets of isomers the meta- or pars-substituent pointed towards, and was in close proximity, to the heme iron. The absence of oxidation activity with 3-methoxybenzoic acid was assigned to the observation that the C-H bonds of this molecule point away from the heme iron. In contrast, in the para isomer they are in an ideal location for abstraction. These findings were confirmed by using the bulkier 3-ethoxybenzoic acid as a substrate which removed the water ligand and reoriented the meta-substituent so that the methylene hydrogens pointed towards the heme, enabling more efficient oxidation. Overall we show relatively small changes in substrate structure and position in the active site can have a dramatic effect on the activity.
    DOI:
    10.1016/j.jinorgbio.2019.110913
  • 作为产物:
    参考文献:
    名称:
    Local Anesthetics. I. β-Monoalkylaminoethyl Esters of Alkoxybenzoic Acids1
    摘要:
    DOI:
    10.1021/ja01259a062
点击查看最新优质反应信息

文献信息

  • Design and synthesis of low molecular weight compounds with complement inhibition activity
    作者:Hoshang E. Master、Shabana I. Khan、Krishna A. Poojari
    DOI:10.1016/j.bmc.2005.04.075
    日期:2005.8
    An attempt was made to synthesize a series of non-cytotoxic low molecular weight compounds of varying substitutions and functionalities having pharmacophore activity like carbonyl compounds, carboxylic acid and bioisosteres like tetrazole and phenyl acrylic acid. The in vitro assay of these analogues for the inhibition of complement activity revealed significant inhibitory activity for varying substituents
    尝试合成一系列具有药效基团活性的,具有不同取代基和功能的,具有不同取代基和官能度的非细胞毒性低分子量化合物,例如羰基化合物,羧酸和生物异构体,例如四唑和苯基丙烯酸。这些类似物在体外对补体活性的抑制作用的测定表明对不同的取代基,特别是对生物等排体,即四唑和苯基丙烯酸衍生物,具有显着的抑制活性。
  • Design, synthesis, and biological studies of novel 3-benzamidobenzoic acid derivatives as farnesoid X receptor partial agonist
    作者:Lijun Hu、Qiang Ren、Liming Deng、Zongtao Zhou、Zongyu Cai、Bin Wang、Zheng Li
    DOI:10.1016/j.ejmech.2020.113106
    日期:2021.2
    Farnesoid X receptor (FXR), a bile acid-activated nuclear receptor, regulates the metabolism of bile acid and lipids as well as maintains the stability of internal environment. FXR was considered as a therapeutic target of liver disorders, such as drug-induced liver injury, fatty liver and cholestasis. The previous reported FXR partial agonist 6 was a suitable lead compound in terms of its high potent
    法尼醇X受体(FXR)是胆汁酸激活的核受体,调节胆汁酸和脂质的代谢,并维持内部环境的稳定性。FXR被认为是肝脏疾病(如药物性肝损伤,脂肪肝和胆汁淤积症)的治疗目标。先前报道的FXR部分激动剂6就其高强度和低分子大小而言是一种合适的先导化合物,而化合物6的对接研究则显示了一个较大的未占据的疏水口袋,这可能为结构活性关系提供了更多可能性(SAR )学习。在这项研究中,我们基于铅化合物6进行了全面的SAR和分子建模研究。所有这些努力导致鉴定出一系列新的FXR部分激动剂。在该系列中,化合物41表现出最佳的活性,并且与FXR的结合口袋有很强的相互作用。此外,化合物41通过调节FXR相关基因的表达并提高抗氧化能力,保护小鼠免受对乙酰氨基酚诱导的肝毒性。总之,这些结果表明化合物41是一种有前途的FXR部分激动剂,适合进一步研究。
  • Correlation of carbon-13 substituent-induced chemical shifts:Meta- andpara-substituted methyl benzoates
    作者:Miloš Buděšńský、Otto Exner
    DOI:10.1002/mrc.1260270612
    日期:1989.6
    Carbon‐13 NMR spectra are reported for 69 substituted methyl benzoates in deuteriochloroform or in its mixture with dimethyl sulphoxide‐d6. The substituent‐induced chemical shifts (SCS) of the CO carbon correlate poorly with dual substituent parameters (DSP) in all possible modifications, and for meta derivatives in particular this correlation is both overpara meterized and imprecise. A much better
    69 取代的苯甲酸甲酯在氘代氯仿中或其与二甲基亚砜-d6 的混合物中的碳 13 NMR 谱报告。在所有可能的修饰中,CO 碳的取代基诱导化学位移 (SCS) 与双取代基参数 (DSP) 的相关性很差,特别是对于间位衍生物,这种相关性既过度参数化又不精确。先前通过主成分分析 (PCA) 从更大的集合中导出的参数(指定为 Bm、Bp 和 Cp)获得了更好的相关性。CH3 碳的 SCS 与原始的简单哈米特方程非常相关,不需要 DSP 处理。在如此大的集合中,取代基的聚类并不重要。
  • [EN] NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS<br/>[FR] NOUVEAUX ANTAGONISTES DU RECEPTEUR DE L'ACETYLCHOLINE MUSCARINIQUE M3
    申请人:GLAXO GROUP LTD
    公开号:WO2005087236A1
    公开(公告)日:2005-09-22
    Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
    提供了肌氢酸乙酰胆碱受体拮抗剂及其使用方法。
  • [EN] COMPOUNDS<br/>[FR] COMPOSÉS
    申请人:UCL BUSINESS LTD
    公开号:WO2020043866A1
    公开(公告)日:2020-03-05
    A compound for use in the treatment of a disease ameliorated by the inhibition of Notum of formula (I): (I)
    一种用于治疗通过抑制公式(I)中的Notum改善的疾病的化合物:(I)
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐